Skip to main content
Liora Schultz, MD, Pediatric Hematology & Oncology, Palo Alto, CA

LioraMichalSchultzMD

Pediatric Hematology & Oncology • Palo Alto, CA

Clinical Assistant Professor, Pediatric Hematology & Oncology

Join to view full profile

Dr. Schultz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schultz's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8000
    Fax+1 650-497-8959

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2010 - 2013
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2007 - 2010
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2025
  • NY State Medical License
    NY State Medical License 2008 - 2014
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Higher Doses of CAR-T Therapy Bring Survival Advantage for Young Patients with Hard-to-Treat B-ALL
    Higher Doses of CAR-T Therapy Bring Survival Advantage for Young Patients with Hard-to-Treat B-ALLAugust 8th, 2022
  • Higher CAR T-cell Dose Linked to Improved Outcomes for Younger Patients with Leukemia
    Higher CAR T-cell Dose Linked to Improved Outcomes for Younger Patients with LeukemiaAugust 8th, 2022
  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
  • Join now to see all

Dr. Liora Schultz, Dr. Liora Schultz, MD, Dr. L Schultz, Dr. Liora Michal Schultz